← Open Payments lookup

MELISSA VITALE: Open Payments

NPI 1952867681 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$21,634 in 62 payments from 10 companies in 2025. Trend: 2023 $45,685 · 2024 $29,993 · 2025 $21,634

Speaker / faculty: $16,280Travel & lodging: $4,147Food & beverage: $1,207
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc42$21,005
ABBVIE INC.5$199
Teva Pharmaceuticals USA, Inc.1$125
E.R. Squibb & Sons, L.L.C.4$69
Otsuka America Pharmaceutical, Inc.2$68
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Lundbeck LLC2$44
Corium, LLC1$26
Takeda Pharmaceuticals U.S.A., Inc.1$19
Bausch Health US, LLC1$16

Products named: INVEGA SUSTENNA, VRAYLAR, UZEDY, REXULTI, COBENFY, CAPLYTA, Azstarys, ABILIFY ASIMTUFII.

Industry payments across IL — which companies pay providers there.